Armenia: Fighting two diseases at once

June 27, 2017
Just a short time ago, Hakobyan was suffering from two deadly diseases: hepatitis C and drug-resistant tuberculosis - neither of which could be treated properly. Today, new drugs have put him on a path to recovery.

 

Just a short time ago, Hakobyan was suffering from two deadly diseases: hepatitis C and drug-resistant tuberculosis - neither of which could be treated properly.

Today, new drugs have put him on a path to recovery.

Watch the short film. produced by MSF:

 

endTB welcomes UNITAID’s Grant extension

26 September 2018

Boston/Paris/Dubai, September 26, 2018. Partners In Health (PIH), Médecins Sans Frontières (MSF), and Interactive Research & Development (IRD) welcome Unitaid’s commitment to ending Tuberculosis, by investing an additional $21 million in the endTB project.

Read more

PIH MSF MSF UNITAID